Daniel Antonio Delgado, MD
Family Medicine · Auburn
- Medicare standing
- 3 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- California licence: Cancelled
- 1 Medical Board action on record
- Washington board action on record
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Delgado’s office at (253) 735-0166 to ask if they take your plan before you enroll.
California Medical Board record
Licence A67685 · Cancelled
Licence status: Cancelled · since 1999 · University of California, Los Angeles School of Medicine. Board flags: Admin Action By Other State/Fed Gov'T.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Public record actions
| 2018-01-31 | Action in another state or by a federal agencyDiscipline | Effective 08/10/17 washington medical license has conditions, assessed a fine, community service and reprimanded. effective 01/31/18 prior order terminated. · Washington medical quality assurance commission |
State licence records
1 licence
- Washington MD.MD.60220369Physician And Surgeon License · since 2011 · expires 2027-08-09
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Medicaid work
$24,511 in 2024
Medicaid paid $24,511 for 957 billed services this clinician did in 2024, up to 32 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 116 | $5,101 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 109 | $4,671 |
| Short return visit (20+ min) | 163 | $4,277 |
| Long return visit (40+ min) | 55 | $3,862 |
| Return visit (30+ min) | 31 | $1,781 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 41 | $1,732 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 83 | $908 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 86 | $769 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 13 | $444 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 39 | $317 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 24 | $270 |
| HEMOGLOBIN | 168 | $181 |
| 2024 | 957 | 14 | 32 | $24,511 |
| 2023 | 2,737 | 23 | 53 | $98,904 |
| 2022 | 1,725 | 19 | 52 | $61,460 |
| 2021 | 1,553 | 9 | 43 | $60,955 |
| 2020 | 1,500 | 12 | 63 | $38,485 |
| 2019 | 1,651 | 8 | 100 | $98,225 |
| 2018 | 1,576 | 11 | 79 | $72,156 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 476 | $22,510 |
| Return visit (30+ min) | 224 | $15,679 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 251 | $13,815 |
| Long return visit (40+ min) | 156 | $13,626 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 189 | $10,897 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 158 | $9,818 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 50 | $2,824 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 198 | $2,487 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 159 | $1,830 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 34 | $1,355 |
| Measurement of lead | 59 | $592 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 47 | $563 |
2022
| Short return visit (20+ min) | 386 | $17,943 |
| Return visit (30+ min) | 159 | $9,245 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 113 | $8,992 |
| Long return visit (40+ min) | 91 | $6,327 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 89 | $5,111 |
| Short return visit | 170 | $4,859 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 38 | $2,509 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 29 | $2,377 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 86 | $1,077 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 48 | $647 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 33 | $540 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 29 | $375 |
2021
| Short return visit (20+ min) | 616 | $22,011 |
| Return visit (30+ min) | 275 | $13,593 |
| Long return visit (40+ min) | 168 | $13,104 |
| Short return visit | 372 | $8,574 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 43 | $1,871 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 40 | $1,555 |
| Clinic visit/encounter, all-inclusive | 12 | $125 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 15 | $65 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $56 |
2020
| Short return visit (20+ min) | 650 | $24,285 |
| Return visit (30+ min) | 213 | $9,439 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 46 | $1,287 |
| Clinic visit/encounter, all-inclusive | 323 | $930 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 112 | $622 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $554 |
| Long return visit (40+ min) | 15 | $512 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 23 | $416 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 48 | $266 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 30 | $143 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 12 | $31 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 16 | $0 |
2019
| Short return visit (20+ min) | 1,035 | $62,441 |
| Return visit (30+ min) | 252 | $23,176 |
| Long return visit (40+ min) | 28 | $3,962 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 32 | $2,898 |
| Short return visit | 59 | $2,144 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 208 | $2,105 |
| Clinic visit/encounter, all-inclusive | 23 | $1,365 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 14 | $134 |
2018
| Short return visit (20+ min) | 752 | $31,797 |
| Return visit (30+ min) | 337 | $19,662 |
| Long return visit (40+ min) | 73 | $6,560 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 80 | $4,980 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 55 | $3,908 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 140 | $1,704 |
| Short return visit | 59 | $1,585 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 28 | $1,570 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 27 | $247 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 13 | $77 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 12 | $66 |
Professional record
- NPI
- 1699738237
- Licence
- CA A67685, WA MD60220369California A67685: CancelledWashington MD.MD.60220369: Active
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Pediatrics (208000000X)
- Mailing address
- 955 Powell Ave Sw, Renton, WA, 98057
- NPI first listed
- 2006-04-06
- NPI last updated
- 2024-12-27
- NPI record certified
- 2024-12-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1993 Mckee Rd, San Jose, CA, 95116
This office lists an electronic records connection.